Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chipping away at diagnostics for neurodegenerative diseases.

Neurobiology of disease - 1 Aug 2009

Scherzer Clemens R

Abstract excerpt

Biomarkers are needed to overcome critical roadblocks in the development of disease-modifying therapeutics for neurodegenerative diseases. Evolving genome-wide expression technologies can comprehensively search for molecular biomarkers and allow fascinating insights into the expanding complexity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to LDL-Receptor Related Proteins
Share to Membrane Transport Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Sclerosis

Share to Neurodegenerative Diseases

Share to Oligonucleotide Array Sequence Analysis

Share to Osteopontin

Source

Open in PubMed Open full text

Identifiers

PMID: 19285134
DOI: 10.1016/j.nbd.2009.02.016
PMCID: PMC2753504

Genes

SORL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19285134-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chipping away at diagnostics for neurodegenerative diseases.PMID 19285134Read ↗

Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead.Semantic proximity Read ↗

Human CSF proteogenomics links genetic variation to neurodegenerative disease proteinsSemantic proximity Read ↗

Biomarkers in neurodegeneration: A beginner’s guide into curated analyses using publicly available datasetsSemantic proximity Read ↗

Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons.Semantic proximity Read ↗

Biomarkers of neurodegenerative disorders: How good are they?Semantic proximity Read ↗

Monoallelic TYROBP deletion is a novel risk factor for Alzheimer's disease.Semantic proximity Read ↗

Monoallelic<i>TYROBP</i>deletion is a novel risk factor for Alzheimer’s diseaseSemantic proximity Read ↗

Nucleic Acid Liquid Biopsies in Alzheimer’s Disease: Current State, Challenges, and OpportunitiesSemantic proximity Read ↗

Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variantsSemantic proximity Read ↗

Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's diseaseSemantic proximity Read ↗

Discovery and development of biomarkers of neurological diseaseSemantic proximity Read ↗

Polymorphisms in neuropsychiatric and neuroinflammatory disorders and the role of next generation sequencing in early diagnosis and treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.